Farook Al-Azzawi. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Bone Density Conservation Agents/therapeutic useBone RemodelingDiphosphonates/therapeutic useEstrogen Replacement Therapy/adverse effectsFemaleFractures, Bone/etiologyFractures, Bone/prevention & controlHumansOsteoporosis, Postmenopausal/complicationsOsteoporosis, Postmenopausal/prevention & control
Substances: See more » Bone Density Conservation AgentsDiphosphonates
Year: 2008 PMID: 19031214 DOI: 10.1080/09513590802296245
Source DB: PubMed Journal: Gynecol Endocrinol ISSN: 0951-3590 Impact factor: 2.260